Ultralife (ULBI) Expected to Announce Quarterly Earnings on Friday

Ultralife (NASDAQ:ULBI) is anticipated to issue its Q1 2026 results before the market opens on Friday, May 8th. Analysts expect the company to announce earnings of $0.15 per share and revenue of $52.40 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Friday, May 8, 2026 at 8:30 AM ET.

Ultralife (NASDAQ:ULBI) last announced its earnings results on Tuesday, March 10th. The technology company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.12). Ultralife had a positive return on equity of 3.10% and a negative net margin of 3.09%.The business had revenue of $48.48 million for the quarter, compared to the consensus estimate of $57.00 million.

Ultralife Stock Up 3.2%

Shares of ULBI opened at $6.83 on Wednesday. Ultralife has a 12 month low of $4.48 and a 12 month high of $9.52. The firm’s 50 day moving average is $6.60 and its 200-day moving average is $6.29. The stock has a market capitalization of $113.79 million, a PE ratio of -18.97 and a beta of 0.74. The company has a current ratio of 2.83, a quick ratio of 1.39 and a debt-to-equity ratio of 0.35.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Empowered Funds LLC bought a new position in shares of Ultralife during the fourth quarter worth approximately $44,000. XTX Topco Ltd increased its stake in Ultralife by 19.9% in the fourth quarter. XTX Topco Ltd now owns 15,456 shares of the technology company’s stock valued at $88,000 after acquiring an additional 2,569 shares during the last quarter. Rothschild Wealth LLC bought a new position in Ultralife in the fourth quarter valued at approximately $400,000. Heron Bay Capital Management bought a new position in Ultralife in the fourth quarter valued at approximately $127,000. Finally, Jane Street Group LLC bought a new position in Ultralife in the fourth quarter valued at approximately $75,000. 30.68% of the stock is owned by institutional investors.

About Ultralife

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.